Featured cases //

Nexium Antitrust Litigation
Wexler Wallace LLP, along with its co-counsel, filed a case on behalf of a class of end-payors (i.e., consumers and third-party payors, such as employee benefit funds and insurers) against AstraZeneca for allegedly entering into non-competition agreements with a number of generic pharmaceutical manufacturers in order to delay market entry of generic versions of its blockbuster drug Nexium.
Read more »

Robert Brown, et al. v. Electrolux Home Products, Inc., d/b/a Frigidaire
Wexler Wallace filed a class action lawsuit against Electrolux Home Products, Inc., alleging that certain models of their Frigidaire-branded front-loading washing machines contained a defect which allowed mold, mildew, and “biofilm” to grow inside the machines. The “biofilm” produces a noxious odor that permeates the washing machines, as well as consumers’ clothing and homes. Plaintiffs allege that they and class members have spent money on repairs and other purported remedies, but none have eliminated the odor problems or “biofilm” growth.
Read more »

Featured Investigations //

Zofran Mass Tort Litigation
Wexler Wallace LLP is actively pursuing cases against GlaxoSmithKline, the manufacturer of the prescription drug Zofran (Ondansetron). Zofran is an anti-nausea medication approved for use by the FDA to treat nausea post-operatively and in patients undergoing cancer therapy. Though never approved for use during pregnancy, Zofran has been extensively promoted and marketed for off-label use to treat women experiencing morning sickness. Due to this off-label promotion, thousands of women have taken Zofran during their first trimester of pregnancy, an extremely significant time of fetal development.
Read more »

Xarelto Litigation
Xarelto, one of a new class of anticoagulants (blood thinners), has been linked to a large number of injuries requiring hospitalizations with some resulting in deaths. Like all blood thinners, Xarelto can cause serious internal bleeding in some. Xarelto bleeding is difficult to stop, as there is currently no known reversal agent for this occurrence, therefore hemorrhaging will continue until the drug is cleared from the system. Wexler Wallace LLP is providing case evaluations for individuals who may have been injured while taking Xarelto.
Read more »

Recent Blog Posts //

Marriage Equality Wins
06/29/2015
I was late to work on Friday. Not because I couldn’t find a taxi, or the dogs were lagging on their morning walk. In fact, I had already started working aroun
Read more »

Will the EPA’s Hydraulic Fracturing Report Affect Litigation?
06/15/2015
On June 4, 2015, the Environmental Protection Agency (EPA) issued its findings on the potential impacts of hydraulic fracturing for oil and gas on drinking wate
Read more »

Guidance for Damages Issues in Class Cases
06/02/2015
How should trial courts deal with challenges to damages models in class actions? The Seventh Circuit recently suggested a burden-shifting approach, in a recent
Read more »